For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
AGM Presentation 2022
ASX Announcement General iTrack Molteno3 AlphaRET
17 Nov, 2022
Glaucoma Surgical Devices Sales Update
ASX Announcement General iTrack Molteno3 AlphaRET
16 Nov, 2022
AlphaRET Completes Initial Recruitment of Investigator Sites for 2RT® Confirmatory Pivotal Study
ASX Announcement General iTrack AlphaRET
24 Oct, 2022
For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
Latest News
See allAGM Presentation 2022
ASX Announcement General iTrack Molteno3 AlphaRET
17 Nov, 2022
Glaucoma Surgical Devices Sales Update
ASX Announcement General iTrack Molteno3 AlphaRET
16 Nov, 2022
AlphaRET Completes Initial Recruitment of Investigator Sites for 2RT® Confirmatory Pivotal Study
ASX Announcement General iTrack AlphaRET
24 Oct, 2022